TD Cowen analyst Steve Scala has reaffirmed his “Buy” rating for AstraZeneca (AZN), signaling continued confidence in the pharmaceutical giant’s…
Read More
TD Cowen analyst Steve Scala has reaffirmed his “Buy” rating for AstraZeneca (AZN), signaling continued confidence in the pharmaceutical giant’s…
Read More